A Promising Approach to Improve Oral Bioavailability of Poorly Soluble Compounds

Oral bioavailability, the fraction of administered dose of a drug that reaches systemic circulation, is a critical determinant of efficacy of many therapeutic agents. Approximately 40% of new chemical entities and more than 90% of currently marketed drugs exhibit poor water solubility, leading to significant challenges in drug formulation and delivery. To address these issues, Eurofins CDMO Alphora employs self emulsifying drug delivery systems (SEDDS) as an innovative solution.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.


  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the phone number you would like to be contacted at.

  • Please enter the e-mail address you would like to be contacted at.

  • By submitting this form, you consent to Pharmaceutical Outsourcing storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.